Eplerenone, a selective mineralocorticoid receptor blocker, exerts anxiolytic effects accompanied by changes in stress hormone release

Endocrine Factors in Stress and Psychiatric Disorders

(2009) Daniela Jezova et al.   Annals of the New York Academy of Sciences

The Role of Mineralocorticoid Receptor Expression in Brain Remodeling after Cerebral Ischemia

(2008) Naofumi Oyamada et al.   ENDOCRINOLOGY

Involvement of vasopressin in affective disorders

(2008) Alexandre Surget et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Mineralocorticoid receptors in brain, in health and disease: Possibilities for new pharmacotherapy

(2008) Michael Kellner et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Chronic treatment with the mineralocorticoid hormone aldosterone results in increased anxiety-like behavior

(2008) Natasa Hlavacova et al.   HORMONES AND BEHAVIOR

Brain Oxytocin: A Key Regulator of Emotional and Social Behaviours in Both Females and Males

(2008) I. D. Neumann   JOURNAL OF NEUROENDOCRINOLOGY

Inhibition of mineralocorticoid receptors with eplerenone alleviates short-term cyclosporin A nephrotoxicity in conscious rats

(2008) F. T. Nielsen et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Elevated plasma arginine vasopressin levels in veterans with posttraumatic stress disorder

(2007) C.S. de Kloet et al.   JOURNAL OF PSYCHIATRIC RESEARCH